AN

Amol Nikam

Active Director Director DIN 10258150
DIN 10258150 First appointment Jul 2023 Primary industry Software
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Amol Nikam

Data last updated:

Amol Nikam is a Director at Sanjeevani Institute Of Medical Sciences Private Limited (since 2023). The company operates in Software.

DIN 10258150
Primary Designation Director
Industry Software
First Appointment 27 Jul 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Jul 20232023Active

Directorship timeline

Open interactive timeline →
Sanjeevani Institute Of Medical Sciences Private Limited
Premium access

Shareholding and investment profile for Amol Nikam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amol Nikam

Amol Nikam currently holds 1 directorship: Sanjeevani Institute Of Medical Sciences Private Limited (Director, since 27 Jul 2023).

Amol Nikam was first appointed on 27 Jul 2023 as Director at Sanjeevani Institute Of Medical Sciences Private Limited.

The current boards of Amol Nikam's companies include Atul Appasaheb Nikam (Sanjeevani Institute Of Medical Sciences Private Limited), Rohini Atul Nikam (Sanjeevani Institute Of Medical Sciences Private Limited), Sugandhimala Amol Nikam (Sanjeevani Institute Of Medical Sciences Private Limited), Vivek Appasaheb Nikam (Sanjeevani Institute Of Medical Sciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available